KT

Kulbhushan Tikoo

Active Director Nominee Director DIN 11266036
DIN 11266036 First appointment Aug 2025
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2025
Shareholding value β€’β€’β€’β€’ Premium profile

About Kulbhushan Tikoo

Data last updated:

Kulbhushan Tikoo is a Nominee Director at Centre For Pharmaceutical Innovation And Entrepreneurship (since 2025).

DIN 11266036
Primary Designation Nominee Director
First Appointment 28 Aug 2025
Oldest Company Age 1 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Nominee Director28 Aug 20252025Active

Board colleagues of Kulbhushan Tikoo

NameDINCompanyDesignation
Dulal Panda11266035Centre For Pharmaceutical Innovation And EntrepreneurshipNominee Director

Directorship timeline

Open interactive timeline →
Centre For Pharmaceutical Innovation And Entrepreneurship
Premium access

Shareholding and investment profile for Kulbhushan Tikoo

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kulbhushan Tikoo

Kulbhushan Tikoo currently holds 1 directorship: Centre For Pharmaceutical Innovation And Entrepreneurship (Nominee Director, since 28 Aug 2025).

Kulbhushan Tikoo was first appointed on 28 Aug 2025 as Nominee Director at Centre For Pharmaceutical Innovation And Entrepreneurship.

The current boards of Kulbhushan Tikoo's companies include Dulal Panda (Centre For Pharmaceutical Innovation And Entrepreneurship).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available